Filter
299
Filtered Results: 299
Text search:
épidémie
Featured
Recommendations
33
New Publications
59
Language
Document type
No document type
119
Guidelines
48
Studies & Reports
41
Situation Updates
19
Fact sheets
19
Strategic & Response Plan
17
Manuals
10
Training Material
8
Resource Platforms
7
Infographics
4
Videos
4
Online Courses
3
Countries / Regions
Germany
39
Congo, Democratic Republic of
38
Burkina Faso
13
Senegal
12
Western and Central Europe
10
Guinea
9
Benin
9
Global
9
Africa
8
Mali
6
Haiti
6
Rwanda
6
Malawi
6
Eastern Europe
6
Niger
5
Madagascar
5
Italy
5
Côte d’Ivoire / Ivory Coast
4
Cameroon
4
West and Central Africa
4
Switzerland
3
Syria
2
Congo-Brazzaville
2
Russia
2
Sierra Leone
1
Liberia
1
Ethiopia
1
Togo
1
South Sudan
1
Lebanon
1
Zambia
1
Central African Republic
1
Austria
1
Burundi
1
Ukraine
1
Yemen
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Luxembourg
1
Djibouti
1
Canada
1
Vietnam
1
Belgium
1
France
1
Authors & Publishers
Publication Years
Category
Countries
110
Clinical Guidelines
28
Public Health
11
Key Resources
9
Women & Child Health
3
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
62
Rapid Response
55
Ebola
40
Global Health Education
23
Cholera
9
HIV
9
TB
9
Mental Health
8
Refugee
7
NCDs
7
Zika
6
Health Financing Toolbox
5
Caregiver
4
Planetary Health
4
Conflict
2
Disability
1
Polio
1
Natural Hazards
1
Specific Hazards
1
Pharmacy
1
Uganda confirmed the first cases of mpox on 24 July 2024 following the confirmation of two case-patients from Kasese District, Bwera Hospital by the Uganda Virus Research Institute (UVRI) through a routine sentinel surveillance system. Cumulatively, 80 confirmed cases of mpox have been registered.
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o...
Situation Report
This course introduces Marburg Virus Disease and outlines the signs, symptoms, diagnosis, transmission routes and epidemiology of the disease. It also discusses prevention and control strategies.
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to discharge.
The Malawi National Strategic Plan (NSP) for HIV and AIDS 2020–2025 is the guiding document for the multi-sectoral response to the HIV epidemic for the next five years. It succeeds the 2015-2020 HIV NSP, building on previous achievements and addressing areas that need improvement with the goal of ...
The document titled "Use of Non-Sugar Sweeteners: WHO Guideline" provides recommendations from the World Health Organization on the use of non-sugar sweeteners (NSS) to reduce sugar intake, manage weight, and prevent diet-related noncommunicable diseases (NCDs). It discusses the potential effects of...
The article "The silent epidemic of COPD in Africa" discusses the under-recognized yet significant prevalence of chronic obstructive pulmonary disease (COPD) in Africa. Despite being the third leading cause of death worldwide, COPD remains poorly studied and largely unknown in sub-Saharan Africa. Th...
WHO has updated the mpox Case reporting form (CRF) and data collection tool, mainly by reducing the number of variables. A detailed list of changes is presented in the file. The content of the Case investigation form (CIF) has not been changed.
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like...
PEPFAR Malawi’s Country Operational Plan 2022 (COP22) embodies joint priorities from national and subnational dialogues building on the 2020-2025 National Strategic Plan for HIV/AIDS. The interagency team has developed a person-centered, district-tailored and Malawi Population-Based HIV Impact Ass...
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
UNAIDS leads the world's most extensive data collection on HIV epidemiology, programme coverage and finance and publishes the most authoritative and up-to-date information on the HIV epidemic.
Men are underrepresented in HIV testing services throughout sub-Saharan Africa. HIV testing is critical to achieve the UNAIDS 95-95-95 goals, as it is the first entry point to HIV care. In Malawi, an estimated 14% of HIV positive men are undiagnosed, while only 6% of HIV positive women remain undiag...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
The article from The Lancet Global Health discusses the "silent epidemic" of chronic obstructive pulmonary disease (COPD) in Africa, emphasizing its status as an under-recognized yet significant health issue. Although COPD is the third leading cause of death globally, it remains largely overlooked i...
The prevalence of asthma and allergic rhinoconjunctivitis is high in western countries, and has been rising throughout the late 20th century. However, relatively little is known about the prevalence of allergic disorders in children in North Africa and the Middle East, and even less is known about t...
Für wen ist eine Laboruntersuchung auf eine Zika Virus-Infektion sinnvoll? Diagnostisches Vorgehen bei Patienten mit und ohne Symptomen
